 This study is to determine, through continuous monitoring with the Reveal implantable cardiac monitor ICM, the incidence of atrial fibrillation AF in patients suspected to be at high risk for having AF and to understand how physicians manage these patients after AF has been detected. This study will also seek to identify what patient characteristics are most predictive of developing AF. 